{
    "SPADE_N_03154": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2004/0072777 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2004_0072777_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2004-4-15",
                "Family Info": "CA2396364A1,EP1246834A1,EP1246834A4,WO2001049702A1",
                "Patent Title": "Epididymal antimicrobial peptides.",
                "Abstract": "The present invention provides novel antimicrobial peptides expressed in the primate epididyrnis (hereinafter, \"EP2 peptides\") and the nucleic acids encoding therefore. EP2 peptides and the nucleic acids encoding therefore can be administered to an individual having a microbial infection in an amount effective to treat the microbial infection or the endogenous production of EP2 peptides can be upregulated to an amount effective to treat the microbial infection. EP2 peptides are useful as antimicrobial agents in animals, including humans, and as antimicrobial agents in agricultural and industrial applications."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_03154",
            "Peptide Name": "Human beta-defensin 2 (hBD-2; Defensin, beta 2; Beta-defensin 4A; Human, mammals, animals)",
            "Source": "Homo sapiens (Human)",
            "Family": "Belongs to the beta-defensin family",
            "Gene": "DEFB4A AND DEFB4B",
            "Sequence": "GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP",
            "Sequence Length": 41,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/O15263",
                "http://www.uniprot.org/uniprot/Q52LC0"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antiviral"
            ],
            "Target Organism": "Gram-negative bacteria:Escherichia coli D31(MIC=62 µg/ml), Escherichia coli ATCC (MIC=62 µg/ml), Pseudomonas aeruginosa ATCC (MIC=62 µg/ml);Gram-positive bacteria:Staphylococcus aureus ATCC (MIC=62 µg/ml), Enterococcus faecalis ATCC (MIC=15 µg/ml).",
            "Hemolytic Activity": "[Ref.15625724] It is slightly hemolytic (<12%) against human erythrocytes at the highest concentration of 500 μg/ml.",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "The structure (one N-terminal helix and 3 beta strands) was found to be monomer in solution (PDB ID: 1E4Q) but a dimer in the crystal (PDB ID: 1FD3).",
            "Formula": "C188H311N55O50S6",
            "Mass": 4334.21,
            "PI": 9.3,
            "Net Charge": 7,
            "Hydrophobicity": -0.1,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Has anti-HIV and antibacterial activity.",
            "Tissue specificity": "Expressed in the skin and respiratory tract.",
            "Induction": "By inflammation.",
            "PTM": "Contains three disulfide bonds 8-37, 15-30, 20-38.",
            "Transgenic plants": "expression of this peptide in Arabidopsis thaliana reduced fungal infection.",
            "Literature": [
                {
                    "Title": "A peptide antibiotic from human skin.",
                    "Pubmed ID": "9202117",
                    "Reference": "Nature. 1997 Jun 26;387(6636)861.",
                    "Author": "Harder J, Bartels J, Christophers E, Schröder JM.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=9202117"
                },
                {
                    "Title": "The structure of human beta-defensin-2 shows evidence of higher order oligomerization.",
                    "Pubmed ID": "10906336",
                    "Reference": "J Biol Chem. 2000 Oct 20;275(42)32911-32918.",
                    "Author": "Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, Chertov O, Lubkowski J.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=10906336"
                },
                {
                    "Title": "Arabidopsis thaliana plants expressing human beta-defensin-2 are more resistant to fungal attack functional homology between plant and human defensins.",
                    "Pubmed ID": "17340092",
                    "Reference": "Plant Cell Rep. 2007 Aug;26(8)1391-1398.",
                    "Author": "Aerts AM, Thevissen K, Bresseleers SM, Sels J, Wouters P, Cammue BP, François IE.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17340092"
                },
                {
                    "Title": "Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation.",
                    "Pubmed ID": "",
                    "Author": "Heng H.H.Q.,Zhao C.,Jia H.P.,Wang L.,Liu L."
                },
                {
                    "Title": "Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells.",
                    "Pubmed ID": "",
                    "Author": "Bevins C.L.,Russell J.P.,Rhodes J.,Kaiser V.,Diamond G."
                },
                {
                    "Title": "Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia.",
                    "Pubmed ID": "R2000J0902",
                    "Author": "Bartels J.,Schwichtenberg L.,Teran L.M.,Meyer-Hoffert U.,Harder J."
                },
                {
                    "Title": "Chemical synthesis of beta-defensins and LEAP-1/hepcidin.",
                    "Pubmed ID": "",
                    "Author": "Adermann K.,Forssmann W.-G.,Schulz A.,Kluever E."
                },
                {
                    "Title": "Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity.",
                    "Pubmed ID": "",
                    "Author": "Forssmann W.-G.,Conejo-Garcia J.-R.,Kluever E.,Schweimer K.,Bauer F."
                },
                {
                    "Title": "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).",
                    "Pubmed ID": "R2004J1449",
                    "Author": ""
                }
            ],
            "Frequent Amino Acids": "CGK",
            "Absent Amino Acids": "EMNOUW",
            "Basic Residues": 8,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 15,
            "Polar Residues": 23,
            "Positive Residues": 8,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_01039",
                    "Similarity": 1.0,
                    "Sequence": "MRVLYLLFSFLFIFLMPLPGVFGGIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP"
                },
                {
                    "SPADE_ID": "SPADE_UN_21530",
                    "Similarity": 1.0,
                    "Sequence": "GIINTLQKYYCRVRGGRCAVLSCLPKEEQIGKCSTRGRKCCRRKKGGGGMGIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP"
                },
                {
                    "SPADE_ID": "SPADE_N_07495",
                    "Similarity": 1.0,
                    "Sequence": "DPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKPP"
                }
            ]
        }
    }
}